EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Nanoparticle-encapsulated Baicalin Inhibits Epithelial-mesenchymal Transition of Lung Cancer Cells Through PI3K/AKT/mTOR Pathway

Lihua Wang, XingHui Ren, Yu Zhou

Pharmacognosy Magazine · 10.08.2026

DOI: 10.1177/09731296261470217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacognosy Magazine, online erschienen am 10.08.2026. Verfasst von Lihua Wang und 2 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chemotherapy is the most important treatment for advanced lung cancer and epithelial-mesenchymal transition (EMT) involves in the drug resistance.

Objectives

Most lung cancer patients will develop drug resistance when they receive treatment, which is related to epithelial-mesenchymal transition (EMT) as a key mechanism that promotes the ability of lung cancer to invade and metastasize. Nanotechnology (NPs), as the main means of targeted delivery of drugs encapsulating baicalin (SA-SS-BAI) extracted from the traditional Chinese medicine Scutellaria baicalensis , plays anti-inflammatory and anti-tumor roles. However, the mechanism of the effect of SA-SS-BAI on EMT has not been clarified. This experiment mainly explores the inhibitory effect of SA-SS-BAI on EMT. Materials and Methods SA-SS-BAI NPs were prepared and observed by particle size, zeta potential, and transmission electron microscope. Human lung cancer cells (A549) were intervened. The A549 cells were assigned to three groups: the control group (Control), the baicalin group (BAI), and the baicalin nanoparticle group (SA-SS-BAI). The changes of SA-SS-BAI NPs on the expression of EMT marker proteins in A549 cells, cell apoptosis, proliferation, invasion, and migration were explored.

Results

SA-SS-BAI can inhibit the EMT of lung cancer cells. This inhibitory effect is mainly through the inhibiting of the phosphorylation of phosphatidylinositol 3-kinase (PI3K), protein kinase B (AKT), and mammalian target of rapamycin (mTOR), reducing cell proliferation, invasion, and migration while increasing the apoptosis rate of cells, and downregulating EMT marker proteins.

Conclusion

SA-SS-BAI can reduce the ability of lung cancer cells, increase the apoptosis rate, and inhibit the ability of EMT by reducing the activity of the PI3K/AKT/mTOR pathway.

Zitieren

APA

Wang, L., Ren, X., & Zhou, Y. (2026). Nanoparticle-encapsulated Baicalin Inhibits Epithelial-mesenchymal Transition of Lung Cancer Cells Through PI3K/AKT/mTOR Pathway. Pharmacognosy Magazine. https://doi.org/10.1177/09731296261470217

Vancouver

Wang L, Ren X, Zhou Y. Nanoparticle-encapsulated Baicalin Inhibits Epithelial-mesenchymal Transition of Lung Cancer Cells Through PI3K/AKT/mTOR Pathway. Pharmacognosy Magazine. 2026. doi:10.1177/09731296261470217

BibTeX
@article{Wang2026,
  author = {Wang, Lihua and Ren, XingHui and Zhou, Yu},
  title = {Nanoparticle-encapsulated Baicalin Inhibits Epithelial-mesenchymal Transition of Lung Cancer Cells Through PI3K/AKT/mTOR Pathway},
  journal = {Pharmacognosy Magazine},
  year = {2026},
  doi = {10.1177/09731296261470217}
}
Kostenlos starten →